How much does a box of Lorlatinib cost?

Lorlatinib (Lorlatinib) is an innovative anti-cancer drug mainly used to treat specific subtypes of non-small cell lung cancer (NSCLC), namely patients with positive ALK (tyrosine kinase) fusion gene. Lorlatinib is approved for the treatment of patients with ALK-positive NSCLC, particularly those with advanced or metastatic disease. It can be used as a first-line or later-line treatment option, providing hope and new treatment opportunities for this patient population.

Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. For details, please consult the local hospital pharmacy. There are original drugs and cheaper generic drugs abroad. The cheaper ones are the original drugs from Turkey, which cost more than 1,000 yuan, and the original drugs from Hong Kong, China, which cost about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.

Patients usually take lorlatinib by mouth once daily, preferably on an empty stomach or at least two hours after a meal to ensure optimal absorption. Although lorlatinib is a targeted drug, some side effects may occur during use, such as fatigue, shortness of breath, nausea, headache, etc. Therefore, patients need regular monitoring and communication with their doctors to ensure optimal treatment results.

In summary, lorlatinib represents an important advance in the treatment of lung cancer, providing patients with ALKpositive NSCLC with a targeted therapy that can improve survival and quality of life. However, before using lorlatinib, patients should consult their physician for detailed treatment options and possible side effects to ensure optimal treatment outcomes.